StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)

Close on Nov 17, 2026Market cap $249.12MP/E –Yield –

Amarin total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Amarin's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0. The highest annual figure on record is $105.01M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$50.13M-37.6%
FY2018Dec 31, 2018$80.35M-13.8%
FY2017Dec 31, 2017$93.18M-7.8%
FY2016Dec 31, 2016$101.10M-2.8%
FY2015Dec 31, 2015$103.99M-1.0%
FY2014Dec 31, 2014$105.01M+4.3%
FY2013Dec 31, 2013$100.69M+18.2%
FY2012Dec 31, 2012$85.15M+11045.7%
FY2011Dec 31, 2011$764.00K+768.2%
FY2010Dec 31, 2010$88.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0-100.0%
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$9.47M-84.2%
Q2 FY2020Jun 30, 2020$22.46M-67.3%
Q1 FY2020Mar 31, 2020$36.98M-50.2%
Q4 FY2019Dec 31, 2019$50.13M-37.6%
Q3 FY2019Sep 30, 2019$60.04M-28.6%
Q2 FY2019Jun 30, 2019$68.61M-21.5%
Q1 FY2019Mar 31, 2019$74.30M-17.3%
Q4 FY2018Dec 31, 2018$80.35M-13.8%
Q3 FY2018Sep 30, 2018$84.05M-12.2%
Q2 FY2018Jun 30, 2018$87.44M-10.9%
Q1 FY2018Mar 31, 2018$89.85M-9.6%
Q4 FY2017Dec 31, 2017$93.18M-7.8%
Q3 FY2017Sep 30, 2017$95.76M–
Q2 FY2017Jun 30, 2017$98.12M–
Q1 FY2017Mar 31, 2017$99.41M–
Q4 FY2016Dec 31, 2016$101.10M–

More Amarin figures

See a number that looks wrong?